Lilly Asia Ventures
Venture Capital
Lilly Asia Ventures (LAV), founded in 2008, is Eli Lilly's corporate VC arm investing in life sciences, healthcare, biotech across Asia and the US.
Seed
Biotech
Healthcare
Life Sciences
- Headquarters
- Shanghai, China
- Founded
- 2008
- Website
- lillyasiaventures.com
- AUM
- $1.2B
- Last Investment
- Jan 2024
- Geographic Focus
- Asia, China, United States
Investment Thesis
Long-term growth investments in biomedical and healthcare innovations, focusing on oncology, IoT, manufacturing in China and Asia-Pacific.
Investment History
Sign up to view investment history
Create a free account to see deal history, investment amounts, and round details.
Create Free Account